|
[1]CHEN L,YANG SM,FANG DC,et al.Idiopathic portal hypertension[J].World Chin J Dig,2004,12(5):1191-1195.(in Chinese)陈陵,杨仕明,房殿春,等.特发性门脉高压症[J].世界华人消化杂志,2004,12(5):1191-1195.
|
|
[2]KHANNA R,SARIN SK.Non-cirrhotic portal hypertension-diagnosis and management[J].J Hepatol,2014,60(2):421-441.
|
|
[3]BANTI G.Splenomeg alie mit leberizirrhose Beitrage zur pathologischen[J].Anat Allgemeinea Pathol,1889,(24):21-33.
|
|
[4]ZHANG BJ,HAN GH,FAN DM.Research advances in non-cirrhotic portal hypertension[J].J Clin Hepatol,2016,32(2):245-249.(in Chinese)张博静,韩国宏,樊代明.非肝硬化性门静脉高压症的研究现状[J].临床肝胆病杂志,2016,32(2):245-249.
|
|
[5]SCHOUTEN JN,VERHEIJ J,SEIJO S.Idiopathic non-cirrhotic portal hypertension:a review[J].Orphanet J Rare Dis,2015,10:67.
|
|
[6]SCHOUTEN JN,GARCIA-PAGAN JC,VALLA DC,et al.Idiopathic noncirrhotic portal hypertension[J].Hepatology,2011,54(3):1071-1081.
|
|
[7]EAPEN CE,NIGHTINGALE P,HUBSCHER SG,et al.Non-cirrhotic intrahepatic portal hypertension:associated gut diseases and prognostic factors[J].Dig Dis Sci,2011,56(1):227-235.
|
|
[8]AUSTIN A,CAMPBELL E,LANE P,et al.Nodular regenerative hyperplasia of the liver and coeliac disease:potential role of IgA anticardiolipin antibody[J].Gut,2004,53(7):1032-1034.
|
|
[9]CARRERAS LO,DEFREYN G,MACHIN SJ,et al.Arterial thrombosis,intrauterine death and“lupus”antiocoagulant:detection of immunoglobulin interfering with prostacyclin formation[J].Lancet,1981,1(8214):244-246.
|
|
[10]MALAMUT G,ZIOL M,SUAREZ F,et al.Nodular regenerative hyperplasia:the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities[J].J Hepatol,2008,48(1):74-82.
|
|
[11]VISPO E,MORENO A,MAIDA I,et al.Noncirrhotic portal hypertension in HIV-infected patients:unique clinical and pathological findings[J].AIDS,2010,24(8):1171-1176.
|
|
[12]SCHOUTEN JN,van der ENDE ME,KOETER T,et al.Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension[J].Aliment Pharmacol Ther,2012,36(9):875-885.
|
|
[13]de BOER NK,TUYNMANH,BLOEMENA E,et al.Histopathology of liver biopsies from a thiopurine-naive inflammatory bowel disease cohort:prevalence of nodular regenerative hyperplasia[J].Scand J Gastroenterol,2008,43(5):604-608.
|
|
[14]VERNIER-MASSOUILLE G,COSNES J,LEMANN M,et al.Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine[J].Gut,2007,56(10):1404-1409.
|
|
[15]NEVENS F,FEVERY J,van STEENBERGEN W,et al.Arsenic and non-cirrhotic portal hypertension.A report of eight cases[J].J Hepatol,1990,11(1):80-85.
|
|
[16]ROULOT D,DEGOTT C,CHAZOUILLERES O,et al.Vascular involvement of the liver in Turner's syndrome[J].Hepatology,2004,39(1):239-247.
|
|
[17]SARIN SK,MEHRA NK,AGARWAL A,et al.Familial aggregation in noncirrhotic portal fibrosis:a report of four families[J].Am J Gastroenterol,1987,82(11):1130-1133.
|
|
[18]KOOT BG,ALDERS M,VERHEIJ J,et al.A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension[J].J Hepatol,2016,64(4):974-977.
|
|
[19]VILARINHO S,SARI S,YILMAZ G,et al.Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension[J].Hepatology,2016,63(6):1977-1986.
|
|
[20]SIRAMOLPIWAT S,SEIJO S,MIQUEL R,et al.Idiopathic portal hypertension:natural history and long-term outcome[J].Hepatology,2014,59(6):2276-2285.
|
|
[21]SCHOUTEN JN,NEVENS F,HANSEN B,et al.Idiopathic noncirrhotic portal hypertension is associated with poor survival:results of a long-term cohort study[J].Aliment Pharmacol Ther,2012,35(12):1424-1433.
|
|
[22]HILLAIRE S,BONTE E,DENNINGER MH,et al.Idiopathic non-cirrhotic intrahepatic portal hypertension in the West:a re-evaluation in 28 patients[J].Gut,2002,51(2):275-280.
|
|
[23]CAZALS-HATEM D,HILLAIRE S,RUDLER M,et al.Obliterative portal venopathy:portal hypertension is not always present at diagnosis[J].J Hepatol,2011,54(3):455-461.
|
|
[24]IBARROLA C,COLINA F.Clinicopathological features of nine cases of non-cirrhotic portal hypertension:current definitions and criteria are inadequate[J].Histopathology,2003,42(3):251-264.
|
|
[25]SARIN SK,KAPOOR D.Non-cirrhotic portal fibrosis:current concepts and management[J].J Gastroenterol Hepatol,2002,17(5):526-534.
|
|
[26]SATO Y,NAKANUMA Y.Role of endothelial-mesenchymal transition in idiopathic portal hypertension[J].Histol Histopathol,2013,28(2):145-154.
|
|
[27]GUIDO M,SARCOGNATO S,SONZOGNI A,et al.Obliterative portal venopathy without portal hypertension:an underestimated condition[J].Liver Int,2016,36(3):454-460.
|
|
[28]SARIN SK,KHANNA R.Non-cirrhotic portal hypertension[J].Clin Liver Dis,2014,18(2):451-476.
|
|
[29]CHANG PE,MIQUEL R,BLANCO JL,et al.Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy[J].Am J Gastroenterol,2009,104(7):1707-1714.
|
|
[30]European Association for the Study of the Liver.EASL clinical practice guidelines:vascular diseases of the liver[J].J Hepatol,2016,64(1):179-202.
|
|
[31]DHIMAN RK,CHAWLA Y,VASISHTA RK,et al.Non-cirrhotic portal fibrosis(idiopathic portal hypertension):experience with151 patients and a review of the literature[J].J Gastroenterol Hepatol,2002,17(1):6-16.
|
|
[32]SARIN SK,AGGARWAL SR.Idiopathic portal hypertension[J].Digestion,1998,59(4):420-423.
|
|
[33]GLATARD AS,HILLAIRE S,D'ASSIGNIES G,et al.Obliterative portal venopathy:findings at CT imaging[J].Radiology,2012,263(3):741-750.
|
|
[34]ARORA A,SARIN SK.Multimodality imaging of obliterative portal venopathy:what every radiologist should know[J].Br J Radiol,2015,88(1046):20140653.
|
|
[35]SEIJO S,REVERTER E,MIQUEL R,et al.Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension[J].Dig Liver Dis,2012,44(10):855-860.
|
|
[36]ZIOL M,HANDRA-LUCA A,KETTANEH A,et al.Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C[J].Hepatology,2005,41(1):48-54.
|
|
[37]NAKANUMA Y,TSUNEYAMA K,HARADA K.Pathology and pathogenesis of intrahepatic bile duct loss[J].J Hepatobiliary Pancreat Surg,2001,8(4):303-315.
|
|
[38]de FRANCHIS R.Expanding consensus in portal hypertension:report of the Baveno VI Consensus Workshop:stratifying risk and individualizing care for portal hypertension[J].J Hepatol,2015,63(3):743-752.
|
|
[39]CHANG PE,GARCIA-PAGAN JC.Idiopathic noncirrhotic portal hypertension in HIV-infected patients[J].Clin Infect Dis,2010,50(1):127-128,128-129.
|
|
[40]SCHIANO TD,KOTLER DP,FERRAN E,et al.Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV[J].Am J Gastroenterol,2007,102(11):2536-2540.
|
|
[41]KRASINSKAS AM,EGHTESAD B,KAMATH PS,et al.Liver transplantation for severe intrahepatic noncirrhotic portal hypertension[J].Liver Transpl,2005,11(6):627-634,610-611.
|
|
[42]HAN M,XU WM,MA AL.Idiopathic portal hypertension:diagnosis and clinical management[J/CD].Chin J Liver Dis:Electronic Edition,2016,8(2):1-4.(in Chinese)韩麦,徐伟民,马安林.特发性门脉高压的诊断和临床处理[J/CD].中国肝脏病杂志:电子版,2016,8(2):1-4.
|
|
[43]RAJEKAR H,VASISHTA RK,CHAWLA YK,et al.Noncirrhotic portal hypertension[J].J Clin Exp Hepatol,2011,1(2):94-108.
|
DownLoad: